Dr. Jerome Hahn Kim, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: Retrovirology, Usamc - Afrims, Apo, AP 96546 Phone: 662-644-4888 Fax: 662-644-4824 |
News Archive
Pending approval of that application, CSL Biotherapies will introduce its influenza vaccine to the U.S. marketplace. The company's BLA requests that the vaccine be approved to immunize people 18 years of age and older.
Rutgers Professor Suzie Chen has found that riluzole, a U.S. Food and Drug Administration (FDA) approved drug used to treat Lou Gehrig's disease (ALS), slows the growth of melanoma, the most aggressive form of malignant skin cancer.
"The question of who is responsible for Haiti's cholera epidemic - the first that the Caribbean nation, the western hemisphere's poorest, has seen in a century - has raised tempers since the first case was detected in October 2010," TIME reports in an article examining a lawsuit filed against the U.N. claiming it is responsible for bringing the disease into the country and seeking damages for cholera victims and their families.
Pharmos Corporation (Pink Sheets: PARS) announced today the results of its Phase 2b Dextofisopam clinical trial to evaluate safety and efficacy of the compound in irritable bowel syndrome.
A new study by UT Southwestern Medical Center researchers is the first to pinpoint damage inside the brains of veterans suffering from Gulf War syndrome - a finding that links the illness to chemical exposures and may lead to diagnostic tests and treatments.
› Verified 9 days ago